Chongrui Xu
12PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS).Anna Li, Wei-Neng Feng, Juan Li
|Jan 06, 2026
Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report.Zi-Rui Ren, Lv Wu, Chang Lu
|Nov 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.Yang-Si Li, Wenpu Lai, Kai Yin
|Jun 09, 2025
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.Li-Bo Tang, Ying-Long Peng, Ji Chen
|Feb 09, 2024
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study.Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin
|Jan 23, 2024
Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.Ying-Long Peng, Zi-Yan Wang, Ri-Wei Zhong
Pageof 2
Frequent Collaborators
5 joint publications
Yi-Long Wu
4 joint publications
Qing Zhou
4 joint publications
Haiyan Tu
3 joint publications
Ying-Long Peng
2 joint publications
Li-Bo Tang
2 joint publications
Hong-Hong Yan
2 joint publications
Yangqiu Li
2 joint publications
Bob T Li
2 joint publications
Charles M Rudin
2 joint publications
Michael Offin
